Low vaccination and infection rate of Omicron in patients with inflammatory bowel disease: a comparative study of three unique cohorts
BackgroundThe SARS-CoV-2 Omicron variant caused a large-scale outbreak of COVID-19 in Shanghai, China. Patients with inflammatory bowel disease (IBD) are at high risk of infection due to immunosuppressive interventions. We aimed to investigate the vaccination information of patients with IBD and upd...
Saved in:
Main Authors: | Jing Feng (Author), Tian Yang (Author), Ruchen Yao (Author), Bo Feng (Author), Renshan Hao (Author), Yuqi Qiao (Author), Jinlu Tong (Author), Jun Shen (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Different Activation of TRAF4 and TRAF6 in Inflammatory Bowel Disease
by: Jun Shen, et al.
Published: (2013) -
Fecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease: An Update
by: Pufang Tan, et al.
Published: (2020) -
New Insights Into the Epigenetic Regulation of Inflammatory Bowel Disease
by: Jing Xu, et al.
Published: (2022) -
Mesenchymal Stem Cell-derived Exosomes: Novel Therapeutic Approach for Inflammatory Bowel Diseases
by: Cheng-mei Tian, et al.
Published: (2023) -
The emerging roles and mechanism of N6-methyladenosine (m6A) modifications in urologic tumours progression
by: Wenhao Zhu, et al.
Published: (2023)